AtaiBeckley (ATAI) Equity Ratio (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Equity Ratio of 0.75 in Q1 2026, down 1.09% quarter-over-quarter from 0.76 in Q4 2025.
AtaiBeckley (ATAI) Equity Ratio (2020 - 2026) Analysis & Trends
AtaiBeckley's Equity Ratio history runs 3 years deep, the most recent figure standing at 0.75 for Q1 2026.
- In Q1 2026, Equity Ratio changed N/A year-over-year to 0.75; the TTM figure through Mar 2026 stood at 0.75 (changed N/A YoY), while the FY2025 annual figure was 0.76, up 3.71% from the prior year.
- Equity Ratio was 0.75 for Q1 2026 at AtaiBeckley, down from 0.76 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q2 2021 to a low of 0.67 in Q3 2025.
- The 5-year median for Equity Ratio is 0.85 (2023), against an average of 0.84.
- Biggest YoY gain for Equity Ratio was 3.71% in 2025; the steepest drop was 3.71% in 2025.
- A 3-year view of Equity Ratio shows it stood at 0.73 in 2024, then grew by 3.71% to 0.76 in 2025, then slipped by 1.09% to 0.75 in 2026.
- The last three Equity Ratio figures came in at 0.75 (Q1 2026), 0.76 (Q4 2025), and 0.73 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 191.07 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 0.04 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.42 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 0.79 |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 0.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.75 |
| Dec 31, 2025 | 0.76 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.76 |
| Mar 31, 2025 | 0.78 |
| Dec 31, 2024 | 0.73 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.74 |
| Jun 30, 2024 | 0.78 |
| Mar 31, 2024 | 0.83 |
| Dec 31, 2023 | 0.83 |
| Jun 30, 2023 | 0.85 |
| Mar 31, 2023 | 0.86 |
| Dec 31, 2022 | 0.87 |
| Sep 30, 2022 | 0.86 |
| Jun 30, 2022 | 0.92 |
| Mar 31, 2022 | 0.92 |
| Dec 31, 2021 | 0.91 |
| Sep 30, 2021 | 0.94 |
| Jun 30, 2021 | 0.96 |